Amlodipine 5 mg + Olmesartan 40 mg: Benefits, Dosage & Precautions

Olmistrum AM 40 is a fixed-dose combination (FDC) antihypertensive tablet manufactured by Steris Healthcare under WHO-GMP and ISO 9001:2018 certified standards, combining two well-established blood pressure-lowering agents—olmesartan medoxomil 40 mg and amlodipine 5 mg—in a single daily tablet.

Hypertension, or high blood pressure, is one of the most common chronic health conditions worldwide, and it often requires more than one mechanism of action to achieve adequate control, particularly in patients whose blood pressure remains elevated despite single-drug therapy. This is where combination antihypertensive therapy, like Olmistrum AM 40, becomes clinically valuable — it addresses blood pressure elevation through two complementary pathways simultaneously, rather than relying on a single mechanism that may not be sufficient on its own.

Amlodipine 5 mg tablet belongs to a class of medications known as calcium channel blockers, which work by relaxing the smooth muscles of blood vessels, while Olmesartan Medoxomil belongs to a class called angiotensin II receptor blockers (ARBs), which block a hormone responsible for narrowing blood vessels. Together, these two mechanisms provide a more comprehensive and often more effective approach to blood pressure management, which is why this combination is widely prescribed by cardiologists and general physicians for patients requiring more robust hypertension control.

Why It's Important

Hypertension is frequently referred to as a "silent" condition because it typically presents with no noticeable symptoms in its early stages, even as it steadily damages blood vessels, the heart, kidneys, and other vital organs over time. Left uncontrolled, chronically elevated blood pressure significantly increases the risk of serious complications, including heart attack, stroke, kidney disease, and heart failure.

A large proportion of hypertensive patients do not achieve adequate blood pressure control with a single antihypertensive medication alone, particularly those with moderate to severe hypertension or additional risk factors such as diabetes, obesity, or a family history of cardiovascular disease. In such cases, relying on monotherapy often means prolonged periods of inadequately controlled blood pressure, during which the risk of organ damage continues to accumulate silently.

This is precisely why combination therapy with olmesartan 40 mg and amlodipine 5 mg has become an important treatment strategy in modern hypertension management. By targeting blood pressure through two distinct and complementary mechanisms, Olmistrum AM 40 helps a larger proportion of patients reach their target blood pressure goals more effectively and often with a lower overall side-effect burden compared to using higher doses of a single agent to achieve the same result.

Key Benefits 

What Are the Benefits of This Combination?

• Dual-Mechanism Blood Pressure Control: Targets hypertension through two complementary pathways for more comprehensive management.
• Effective for Difficult-to-Control Hypertension: Particularly beneficial for patients who do not achieve target blood pressure with a single antihypertensive agent.
• Convenient Single-Tablet Therapy: Combines two medications into one tablet, simplifying the treatment regimen and improving adherence.
• Reduced Risk of Cardiovascular Complications: Effective blood pressure control helps lower the long-term risk of heart attack, stroke, and kidney damage.
• Well-Tolerated Combination: The complementary mechanisms may help offset certain side effects associated with higher doses of individual components.
• Suitable for Long-Term Management: Designed for sustained, once-daily use in chronic hypertension management.
• Broad Clinical Support: Both olmesartan and amlodipine are extensively studied medications with well-established efficacy and safety profiles.

Indications 

Healthcare providers commonly prescribe Olmistrum AM 40 for:

• Essential hypertension not adequately controlled by monotherapy
• Patients requiring more aggressive blood pressure management due to elevated cardiovascular risk
• Hypertensive patients with additional risk factors such as diabetes or obesity
• Long-term maintenance therapy for chronic high blood pressure
• Patients who experience side effects from higher doses of a single antihypertensive agent and require a combination approach at lower individual doses

Side Effects

While Olmistrum AM 40 is generally well-tolerated, some patients may experience mild side effects, particularly during the initial period of treatment:

• Dizziness or lightheadedness, especially when standing up quickly
• Headache
• Swelling of the ankles or feet (peripheral edema), more commonly associated with amlodipine
• Fatigue or tiredness
• Flushing (warmth or redness of the skin)
• Mild gastrointestinal discomfort, such as nausea

These effects are typically mild and tend to diminish as the body adjusts to the medication. If symptoms persist or become bothersome, consulting a healthcare provider is recommended.

Available Substitutes

The market offers several fixed-dose combinations of olmesartan medoxomil and amlodipine, as well as alternative ARB-calcium channel blocker combinations from various manufacturers. While the active ingredients may be similar across brands, differences in formulation technology, tablet dissolution, and manufacturing quality can affect the consistency and bioavailability of the medication. Olmistrum AM 40, manufactured by Steris Healthcare in a WHO-GMP certified facility, is formulated with precise, standardized dosing to ensure reliable and consistent therapeutic effect with every tablet. Before switching to any alternative combination product, it is important to consult a healthcare provider, as changes in antihypertensive therapy should always be made under medical supervision to avoid fluctuations in blood pressure control.

Dosage Guidelines 

The dosage of Olmistrum AM 40 is always individualized by a healthcare provider based on the patient's blood pressure levels, response to therapy, and any coexisting health conditions. Self-adjusting the dosage without medical guidance can lead to inadequate blood pressure control or increased risk of side effects.

Precautions & Warnings

• This medication should not be used during pregnancy, as it can cause serious harm to the developing fetus; women who become pregnant while on this medication should stop taking it and contact their doctor immediately.
• Breastfeeding mothers should consult a healthcare provider before using this medication.
• Patients with a history of liver or kidney disease should inform their doctor before starting treatment, as dose adjustments may be necessary.
• Avoid sudden standing after prolonged sitting or lying down, especially in the initial days of treatment, to reduce the risk of dizziness.
• Regular monitoring of blood pressure, kidney function, and electrolyte levels is recommended during long-term therapy.
• Inform your doctor of all other medications, supplements, or herbal products you are taking, as certain combinations (such as with potassium supplements or certain diuretics) may require monitoring.
• Do not stop this medication abruptly without consulting your doctor, even if your blood pressure appears to be under control, as this can lead to a sudden rise in blood pressure.

Mechanism of Action 

Understanding the combined mechanism of action behind Olmistrum AM 40 helps explain why this dual-therapy approach is so effective for blood pressure management.

Olmesartan Medoxomil 40mg: Olmesartan is an angiotensin II receptor blocker (ARB). It works by selectively blocking the AT1 receptor, which is the site where angiotensin II — a hormone that causes blood vessels to constrict (narrow) — normally binds. By blocking this receptor, olmesartan medoxomil prevents the vessel-narrowing and blood pressure-raising effects of angiotensin II, resulting in relaxed, widened blood vessels and reduced overall vascular resistance. This translates directly into lower blood pressure readings.

Amlodipine 5mg: Amlodipine belongs to the dihydropyridine class of calcium channel blockers. It works by inhibiting the movement of calcium ions into the smooth muscle cells lining blood vessel walls. Since calcium ions are essential for muscle contraction, blocking their entry causes the smooth muscles of arterial walls to relax, leading to vasodilation (widening of blood vessels) and, consequently, reduced blood pressure.

When combined, olmesartan 40 mg and amlodipine 5 mg tablet target blood pressure through two distinct physiological pathways — hormonal (renin-angiotensin system) and cellular (calcium channel) — providing a synergistic effect that is often more effective at controlling blood pressure than either agent used alone, while also helping to offset certain side effects that might occur with higher doses of a single medication.

Frequently Asked Questions 

1. What is Olmistrum AM 40 used for?
Olmistrum AM 40 is used to manage high blood pressure (hypertension) through the combined action of Olmesartan Medoxomil and Amlodipine.

2. What are the main amlodipine 5 mg tablet uses?
Amlodipine 5 mg is primarily used to treat high blood pressure and certain types of chest pain (angina) by relaxing blood vessels.

3. How does olmesartan 40 mg work?
Olmesartan blocks the action of angiotensin II, a hormone that narrows blood vessels, helping to relax and widen them to lower blood pressure.

4. What is the best time to take tab amlodipine 5 mg with olmesartan?
It is best taken at the same time each day, with or without food, as advised by your doctor.

5. What are common olmesartan medoxomil uses?
Olmesartan medoxomil is primarily used to treat hypertension, either alone or in combination with other antihypertensive agents like amlodipine.

6. Can amlodipine 5 mg cause swelling in the legs?
Yes, mild swelling of the ankles or feet (peripheral edema) is a known side effect associated with amlodipine.

7. What is olmesartan 40 mg price?
Pricing varies by brand and packaging; please contact your local pharmacy or Steris Healthcare for exact pricing details.

8. Is Olmistrum AM 40 safe for long-term use?
Yes, it is designed for long-term hypertension management, with regular monitoring by a healthcare provider.

9. Can this medication be taken during pregnancy?
No, this medication should not be used during pregnancy due to potential risk of harm to the fetus.

10. What are the amlodipine 5 mg uses in hindi?
अम्लोडिपिन 5mg का उपयोग मुख्य रूप से उच्च रक्तचाप और एनजाइना (सीने में दर्द) के प्रबंधन के लिए किया जाता है।

11. Are there serious side effects of olmesartan medoxomil tablets?
Rare serious side effects include severe allergic reactions, very low blood pressure, and kidney function changes — seek medical attention if these occur.

12. Can I stop taking Olmistrum AM 40 suddenly?
No, stopping abruptly without medical guidance can cause a sudden increase in blood pressure — always consult your doctor first.

13. Does amlodipine 5 mg interact with other medications?
Yes, it may interact with certain medications; always inform your doctor of all drugs and supplements you are taking.

14. Is a prescription required for Olmistrum AM 40?
Yes, this is a prescription medication and should only be used under the guidance of a registered healthcare provider.

15. What happens if I miss a dose?
Take it as soon as you remember; if the next dose is due soon, skip the missed one — do not take a double dose.

16. Can Olmistrum AM 40 be used in patients with kidney disease?
Dose adjustment may be necessary in patients with kidney impairment — always inform your doctor of your medical history.

Conclusion

Olmistrum AM 40, combining Olmesartan Medoxomil 40mg and Amlodipine 5mg, offers a scientifically robust, dual-mechanism approach to managing hypertension, particularly for patients who require more comprehensive blood pressure control than single-agent therapy can provide. By addressing blood pressure elevation through both the renin-angiotensin system and calcium channel pathways, this combination therapy delivers more consistent and effective blood pressure management while helping to reduce the long-term risk of cardiovascular complications. Manufactured by Steris Healthcare under WHO-GMP and ISO 9001:2018 certified standards, Olmistrum AM 40 reflects a strong commitment to quality, consistency, and patient safety in every tablet. As with any antihypertensive medication, treatment should always be initiated, monitored, and adjusted under the guidance of a qualified healthcare professional.

For Further Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now